Introduction
Obesity has become a major global health challenge, contributing to conditions such as type 2 diabetes, cardiovascular disease, fatty liver disease, and hypertension. While lifestyle changes and medications can help some individuals lose weight, many patients struggle to achieve long-term results.
In recent years, gastroenterology has introduced new minimally invasive techniques for weight management. One of the most promising advancements is Endoscopic Sleeve Gastroplasty (ESG), a non-surgical procedure that reduces the size of the stomach using an endoscope. This innovative technique offers an effective weight-loss option without the need for traditional bariatric surgery.
What is Endoscopic Sleeve Gastroplasty?
Endoscopic Sleeve Gastroplasty is a minimally invasive procedure performed by gastroenterologists using a flexible endoscope inserted through the mouth into the stomach.
During the procedure, a specialized suturing device places a series of stitches inside the stomach. These sutures fold and tighten the stomach, reducing its size and reshaping it into a narrow tube. As a result, the stomach holds less food and patients feel full more quickly after eating.
Unlike traditional bariatric surgery, ESG does not require external incisions, making it a less invasive option for weight loss treatment.
How the Procedure Works
The ESG procedure typically involves the following steps:
A flexible endoscope is passed through the mouth into the stomach.
A specialized endoscopic suturing device is used to place internal stitches.
These stitches reduce the stomach’s volume by creating folds in the stomach wall.
The reshaped stomach limits food intake and promotes earlier satiety.
The entire procedure usually takes about 60 to 90 minutes and is commonly performed as an outpatient treatment.
Benefits of Endoscopic Sleeve Gastroplasty
Endoscopic Sleeve Gastroplasty offers several advantages compared with traditional surgical weight-loss procedures.
Minimally invasive procedure
No surgical incisions are required, reducing the risk of complications.
Shorter recovery time
Most patients return to normal activities within a few days.
Effective weight loss
Clinical studies show patients may lose approximately 15–20% of their total body weight within one to two years when combined with lifestyle changes.
Improved metabolic health
Weight loss achieved through ESG may improve obesity-related conditions such as diabetes, hypertension, and fatty liver disease.
Why This Innovation Matters
Endoscopic Sleeve Gastroplasty represents an important advancement in the field of bariatric endoscopy. It bridges the gap between lifestyle interventions and major bariatric surgery.
For patients who are not candidates for surgical procedures or prefer a less invasive option, ESG provides a promising alternative. The procedure allows gastroenterologists to offer effective weight-loss therapy while minimizing surgical risks.
Future Outlook
The future of obesity treatment is expected to involve a combination of innovative therapies. Endoscopic procedures like ESG may be used alongside metabolic medications, nutritional therapy, and digital health monitoring to create more personalized weight-management strategies.
As research continues to advance, minimally invasive techniques such as ESG are likely to play an increasingly important role in the treatment of obesity and metabolic diseases.
References
Johns Hopkins Medicine – Endoscopic Sleeve Gastroplasty JHM
American Society for Metabolic and Bariatric Surgery – ESG Overview asmbs
PubMed – Clinical outcomes of Endoscopic Sleeve Gastroplasty pubmed